US 12,178,801 B1Granted

Stable psilocin salts, esters and conjugates and uses thereof

AssigneeLobe Sciences Ltd.

InventorsYousry Sayed, Frederick Sancilio, Shaileshkumar Ramanlal Desai, Autumn Beauchamp

Life of this patent

Estimating the term…

Abstract

Pharmaceutically acceptable salts, esters and conjugates of psilocin and compositions and methods for their production and use in treating diseases or conditions treatable with psilocin or psilocybin are provided.

Claims8

Dependent claims

A composition comprising a psilocin mucate salt or conjugate.

Dependencies are inferred from the claim text.

Facts

Application: 18/818,317Filed 28 Aug 2024 · continuation in part
Priority: 12 Jul 2022
Published: US 2024/0415813 A119 Dec 2024
Granted: 31 Dec 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61K 31/4045
Indoles, e.g. pindolol: indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 47/542
The modifying agent being an organic compound: carboxylic acids, e.g. a fatty acid or an amino acid
A61K 47/545
The modifying agent being an organic compound: heterocyclic compounds

Family

Application63/388,414Us provisional application · filed 12 Jul 2022
PCT/US2023/027500Parent of this continuation-in-part · filed 12 Jul 2023
US 2024/0415813 A1Published application
US 12,178,801 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results